Google policy
Last week, three Democratic committees condemned Google’s new policy that allows false advertisements on its platforms. (Photo by: AlexHliv/Shutterstock.com)

Three Democratic Committees Condemn Google’s Policy Allowing False Advertisements

Last week, three Democratic committees condemned Google’s new policy that allows false advertisements on its platforms.

On Wednesday, Google announced its new policy that limits the ways ads can be targeted. They can’t be offered by political affiliation, but they can be targeted by age, gender and postal code.

The policy did not include anything about an advertisement needing to be true if it is targeting another candidate. Politicians can run advertisements that contain falsehoods, as long as the subject of the ad is not about voter suppression and election integrity.

On Friday, a statement from the Democratic National Committee (DNC), Democratic Senatorial Campaign Committee (DSCC) and Democratic Congressional Campaign Committee (DCCC) provided to CNN read, in part: “We stand in full support of tech platforms removing demonstrably false content and instituting better transparency standards. That approach combats the spread of disinformation without harming civic engagement or limiting the ability of campaigns to connect directly with voters … Tech companies should not reduce the power of the grassroots just because it is easier than addressing abuse on their platforms.”

Related Article: On Twitter, Activists, Businesses Can Advertise Causes, But Political Ads Still Banned

One advertisement, in particular, from the Trump reelection campaign that falsely accused former Vice President Joe Biden of corruption in Ukraine, was brought up to Google.

That ad can run on all of Google’s platforms, despite it being untrue.

“We call on these tech companies, including Google, to reconsider their decision to bluntly limit political advertising on their platforms, and we invite them to engage in an open and transparent conversation about how we effectively regulate political advertising online,” the joint statement from DNC CEO Seema Nanda, DSCC executive director Scott Fairchild and DCCC executive director Lucinda Guinn said. “We view this as critical to combating the spread of disinformation in paid communications, and vital to our ability to empower voters with true and accurate information.”

Leave a Comment

Your email address will not be published. Required fields are marked *

*

Latest News

Humana Announces New Care Coordination Services for Members with Kidney Disease

Originally posted on Humana.com Designed To Improve the Patient Experience and Health Outcomes, Services to be Available Initially in Four States Leading health and well-being company Humana Inc. (NYSE: HUM) Monogram Health and Somatus, Humana will offer care coordination to better diagnose and manage kidney disease toward improving members’ quality of life and…

Mastercard and Doconomy Extend Collaboration to Deliver a More Sustainable Future

Originally published on Mastercard.com. S&P Global Joins Effort to Power Global Platform Available to All Issuers Further Support Provided by Mastercard Investment in Doconomy Madrid COP25, December 10, 2019 – Doconomy and Mastercard today extended their joint effort to combat climate change. Moving beyond previously announced programs, this new arrangement brings the ability…

As Change Accelerates, Insurers Need Profound Transformation and the Right Talent, Reveals EY Insurance Outlook 2020

Originally posted on EY.com Declining interest rates, changing customer expectations and shifting demographics are defining the future of insurance Insurers must strike the right balance between achieving operational excellence and investing in technology-led innovation As insurance industry growth remains stagnant for another year due to low interest rates, the shifts…

AbbVie and Scripps Research Announce Collaboration to Develop a Broad Range of New Therapeutics

Originally posted on Abbvie.com AbbVie, a research-based global biopharmaceutical company and Scripps Research, an international leader in non-profit biomedical research and drug discovery, today announced a collaboration to develop new therapies for a range of diseases, including in the therapeutic areas of oncology, immunology, neurology, and fibrosis. “Based on our…